Metrics as of 10/16/2026, 02:59 AM (Berlin time), refresh in progress.
CapsoVision Stock
CapsoVision, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Kang-Huai Wang
- Employees
- 99
- Market cap
- $343 M
- IPO
- 02/07/2025
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above;…
CapsoVision stock: price history
1D
-2.9%
1W
-2.6%
1M
+1.1%
6M
+19.4%
YTD
-39.7%
1Y
+36.9%
2Y
–
5Y
–
10Y
–
Next earnings date
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~19% stronger price swings than usual
Ask the agents about CapsoVision
Analyst assessment of CapsoVision
PRICE TARGET LOW
US$9.00
CONSENSUS
US$9.00
MEDIAN
US$9.00
PRICE TARGET HIGH
US$9.00
0
STRONG BUY
1
BUY
0
HOLD
0
SELL
0
STRONG SELL
1
TOTAL · Buy
As of: 27/03/2026
CapsoVision stock metrics
P/E
-10.24
P/B
24.46
EV/EBITDA
-11.43
RETURN ON EQUITY
-56.8%
NET MARGIN
-205.4%
DEBT/EQUITY
0.05
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
7.9%
FLOAT SHARES
4,179,772
AVG. DAILY VOLUME (30D)
233,626
Insider transactions (SEC)
HARARI ELIYAHOU ET AL
HARARI ELIYAHOU ET AL
Shen Ching Hang
HARARI ELIYAHOU ET AL
HARARI ELIYAHOU ET AL
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -2.9%
Forums (Reddit)
Institutional holders
Comparable stocks
Frequently asked questions about CapsoVision stock
What does CapsoVision do?
CapsoVision, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Kang-Huai Wang, the company employs around 99 people.
The IPO was on 02/07/2025; the stock trades on NASDAQ under the ticker CV.
What do analysts say about CapsoVision stock?
1 analysts rate the stock, the consensus is Buy (as of 27/03/2026).
The average price target is US$9.00, ranging from US$9.00 to US$9.00, with a median of US$9.00.
This is an external assessment, not a statement by Market Jury.
When does CapsoVision report next?
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly 19% stronger than usual.
Does CapsoVision pay a dividend?
No, CapsoVision currently does not pay a dividend.
Which stocks are comparable to CapsoVision?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get CapsoVision stock analyzed?
Clicking "Analyze stock" lets five strategies assess CapsoVision against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.